Andexanet alfa
Andexanet alfa is a recombinant protein that is used as an antidote to reverse the anticoagulant effects of direct factor Xa inhibitors. It is a modified form of the human Factor X protein.
Etymology[edit | edit source]
The name "andexanet alfa" is derived from "antidote for Xa inhibitors" and "alfa" is a common suffix for recombinant proteins.
Mechanism of action[edit | edit source]
Andexanet alfa works by binding to direct factor Xa inhibitors, preventing them from inhibiting the activity of factor Xa. This allows the normal clotting process to resume.
Uses[edit | edit source]
Andexanet alfa is used to reverse the anticoagulant effects of direct factor Xa inhibitors in patients who are experiencing serious or uncontrolled bleeding or who require urgent surgery.
Side effects[edit | edit source]
Common side effects of andexanet alfa include nausea, vomiting, and headache. Serious side effects can include thrombosis and ischemia.
History[edit | edit source]
Andexanet alfa was approved for medical use in the United States in 2018. It is marketed under the brand name Andexxa by Portola Pharmaceuticals.
See also[edit | edit source]
| Andexanet alfa Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
